392 related articles for article (PubMed ID: 18515243)
1. Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors.
Anderson NJ; Hacker ED
Clin J Oncol Nurs; 2008 Jun; 12(3):445-54. PubMed ID: 18515243
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal chemotherapy for women with ovarian cancer: nursing care and considerations.
Potter KL; Held-Warmkessel J
Clin J Oncol Nurs; 2008 Apr; 12(2):265-71. PubMed ID: 18390462
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cancer.
Fitch MI; Turner F
Can Nurse; 2006 Jan; 102(1):16-20. PubMed ID: 16468226
[TBL] [Abstract][Full Text] [Related]
4. Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer.
Sun V; Otis-Green S; Morgan R; Wakabayashi M; Hakim A; Callado ME; Yang E; Ferrell B; Grant M
Eur J Oncol Nurs; 2013 Jun; 17(3):375-80. PubMed ID: 23153453
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal chemotherapy: implications beyond ovarian cancer.
Marin K; Oleszewski K; Muehlbauer P
Clin J Oncol Nurs; 2007 Dec; 11(6):881-9. PubMed ID: 18063547
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based research for intraperitoneal chemotherapy in epithelial ovarian cancer.
Almadrones L
Clin J Oncol Nurs; 2007 Apr; 11(2):211-6. PubMed ID: 17573270
[TBL] [Abstract][Full Text] [Related]
7. Pros and cons of intraperitoneal chemotherapy in the treatment of epithelial ovarian cancer.
Zeimet AG; Reimer D; Radl AC; Reinthaller A; Schauer C; Petru E; Concin N; Braun S; Marth C
Anticancer Res; 2009 Jul; 29(7):2803-8. PubMed ID: 19596965
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal access via direct puncture is an alternative way to deliver intraperitoneal chemotherapy in ovarian, fallopian tube and primary peritoneal cancer.
Lan C; Li Y; Liu J
Gynecol Oncol; 2009 Jul; 114(1):42-7. PubMed ID: 19398124
[TBL] [Abstract][Full Text] [Related]
9. ACOG Committee Opinion No. 396. Intraperitoneal chemotherapy for ovarian cancer.
American College of Obstetricians and Gynecologists
Obstet Gynecol; 2008 Jan; 111(1):249. PubMed ID: 18165421
[TBL] [Abstract][Full Text] [Related]
10. [Intraperitoneal chemotherapy in first-line combination treatment for advanced ovarian cancer].
Massard C; Lhommé C; Pautier P
Bull Cancer; 2007 Apr; 94(4):398-404. PubMed ID: 17449443
[TBL] [Abstract][Full Text] [Related]
11. An outpatient intraperitoneal chemotherapy regimen for advanced ovarian cancer.
Berry E; Matthews KS; Singh DK; Buttin BM; Lurain JR; Alvarez RD; Schink J
Gynecol Oncol; 2009 Apr; 113(1):63-7. PubMed ID: 19201457
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal chemotherapy for ovarian cancer: overview and perspective.
Rao G; Crispens M; Rothenberg ML
J Clin Oncol; 2007 Jul; 25(20):2867-72. PubMed ID: 17617517
[TBL] [Abstract][Full Text] [Related]
13. Fatigue in cancer patients. A descriptive study.
Pickard-Holley S
Cancer Nurs; 1991 Feb; 14(1):13-9. PubMed ID: 2013047
[TBL] [Abstract][Full Text] [Related]
14. Practice patterns of intraperitoneal chemotherapy in women with ovarian cancer.
Naumann RW; Sukumvanich P; Edwards RP
Gynecol Oncol; 2009 Jul; 114(1):37-41. PubMed ID: 19410281
[TBL] [Abstract][Full Text] [Related]
15. WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms.
Kearney N; Miller M; Maguire R; Dolan S; MacDonald R; McLeod J; Maher L; Sinclair L; Norrie J; Wengström Y
Eur J Oncol Nurs; 2008 Dec; 12(5):443-8. PubMed ID: 18842457
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer: an overview.
Roett MA; Evans P
Am Fam Physician; 2009 Sep; 80(6):609-16. PubMed ID: 19817326
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.
Chin SN; Pinto V; Rosen B; Oza A; Dodge J; Murphy J; Mackay H
Gynecol Oncol; 2009 Mar; 112(3):450-4. PubMed ID: 19135709
[TBL] [Abstract][Full Text] [Related]
18. Ip immunotherapy and chemotherapy in advanced epithelial ovarian cancer.
Hernandez E; Rosenshein NB; Pino y Torres J; Villar J; Grumbine FC; Ettinger DS; Dillon MB; Klein JL; Order SE
Cancer Treat Rep; 1982 Nov; 66(11):1981-2. PubMed ID: 7139641
[TBL] [Abstract][Full Text] [Related]
19. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses.
Kearney N; Friese C
Eur J Oncol Nurs; 2008 Feb; 12(1):14-25. PubMed ID: 18291720
[TBL] [Abstract][Full Text] [Related]
20. Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy.
Payne JK; Held J; Thorpe J; Shaw H
Oncol Nurs Forum; 2008 Jul; 35(4):635-42. PubMed ID: 18591167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]